Spk-8011: Preliminary Results from a Phase 1/2 Dose Escalation Trial of an Investigational AAV-Mediated Gene Therapy for Hemophilia a

被引：0
|
作者：
George, Lindsey A.
Ragni, Margaret V.
Samelson-Jones, Ben J.
Cuker, Adam
Runoski, Alexa R.
Cole, Grace
Wright, Fraser
Chen, Yifeng
Hui, Daniel J.
Wachtel, Katie
Takefman, Daniel
Couto, Linda B.
Reape, Kathleen Z.
Carr, Marcus E.
Anguela, Xavier M.
High, Katherine A.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
604
引用
收藏
页数：2
相关论文
共 50 条
  • [1] SPK-8011: Preliminary results from a phase 1/2 trial of investigational gene therapy for hemophilia A
    George, L. A.
    Ragni, M.
    Sullivan, S. K.
    Barrett, J. C.
    Samelson-Jones, B. J.
    Cuker, A.
    Cole, G.
    Wright, F.
    Chen, Y.
    Hui, D. J.
    Liu, Y.
    Wachtel, K.
    Takefman, D.
    Couto, L. B.
    Reape, K.
    Carr, M. E.
    Anguela, X. M.
    High, K. A.
    HAEMOPHILIA, 2018, 24 : 30 - 31
  • [2] Rapid Clearance of Vector Following AAV-Mediated FVIII Gene Transfer in the Phase I/II Trial of SPK-8011 in People with Hemophilia A
    Huyen Tran
    Eyster, M. Elaine
    Croteau, Stacy E.
    Ragni, Margaret, V
    Samelson-Jones, Benjamin J.
    Sullivan, Spencer
    Rasko, John E. J.
    Jaworski, Kristen
    MacDougall, Amy
    Jaeger, Savina
    Hofer, Magdalena
    Li, Charlie
    Mingozzi, Federico
    Chang, Tiffany
    Levy, Gallia
    BLOOD, 2022, 140 : 10662 - 10664
  • [3] A Phase 1/2 Trial of Investigational Spk-8011 in Hemophilia a Demonstrates Durable Expression and Prevention of Bleeds
    High, Katherine A.
    George, Lindsey A.
    Eyster, M. Elaine
    Sullivan, Spencer K.
    Ragni, Margaret V.
    Croteau, Stacy E.
    Samelson-Jones, Ben J.
    Evans, Matthew
    Joseney-Antoine, Marcelyne
    Macdougall, Amy
    Kadosh, Judith
    Runoski, Alexa R.
    Campbell-Baird, Cynthia
    Douglas, Kayla
    Tompkins, Summer
    Hait, Howard
    Couto, Linda B.
    Bassiri, Ashlyn Eaton
    Valentino, Leonard A.
    Carr, Marcus E.
    Hui, Daniel J.
    Wachtel, Katie
    Takefman, Daniel
    Mingozzi, Federico
    Anguela, Xavier M.
    Reape, Kathleen B.
    BLOOD, 2018, 132
  • [4] SPK-8011: Preliminary Results from a Phase 1/2 Trial of Investigational Gene Therapy for Hemophilia Confirm Transgene Derived Increases in FVIII Activity That Are Persistent and Stable beyond Eight Months
    Sullivan, Spencer K.
    George, Lindsey A.
    Ragni, Margaret V.
    Samelson-Jones, Ben
    Cuker, Adam
    Chen, Yifeng
    Hui, Daniel J.
    Wachtel, Katie
    Takefman, Daniel
    Couto, Linda B.
    Carr, Marcus E.
    Reape, Kathleen Z.
    Anguela, Xavier M.
    High, Katherine A.
    MOLECULAR THERAPY, 2018, 26 (05) : 163 - 163
  • [5] SPK-8016: PRELIMINARY RESULTS FROM A PHASE 1/2 CLINICAL TRIAL OF GENE THERAPY FOR HEMOPHILIA A
    Sullivan, S. K.
    Barrett, J. C.
    Drelich, D. A.
    Tarantino, M. D.
    MacDougall, A.
    Joseney-Antoine, M.
    Wachtel, K.
    Jaworski, K.
    Curran, M.
    Kuranda, K.
    Armour, S. M.
    Mingozzi, F.
    Anguela, X. M.
    Reape, K. Z.
    Monahan, P. E.
    High, K. A.
    HAEMOPHILIA, 2021, 27 : 129 - 130
  • [6] Long-Term Durable FVIII Expression with Improvements in Bleeding Rates Following AAV-Mediated FVIII Gene Transfer for Hemophilia A: Multiyear Follow-up on the Phase I/II Trial of SPK-8011
    Croteau, Stacy E.
    Eyster, M. Elaine
    Huyen Tran
    Ragni, Margaret, V
    Samelson-Jones, Benjamin J.
    George, Lindsey
    Sullivan, Spencer
    Rasko, John E. J.
    Moormeier, Jill
    Angchaisuksiri, Pantep
    Teitel, Jerome
    Kenet, Gili
    Wynn, Tung
    Jaworski, Kristen
    Macdougall, Amy
    Jaeger, Savina
    Trivedi, Trupti
    Mingozzi, Federico
    Chang, Tiffany
    Levy, Gallia
    BLOOD, 2022, 140 : 1899 - 1901
  • [7] The treatment of hemophilia A: from protein replacement to AAV-mediated gene therapy
    Shen Youjin
    Yin Jun
    BIOTECHNOLOGY LETTERS, 2009, 31 (03) : CP7 - CP14
  • [8] The treatment of hemophilia A: from protein replacement to AAV-mediated gene therapy
    Shen Youjin
    Yin Jun
    Biotechnology Letters, 2009, 31 : 321 - 328
  • [9] A phase I trial of AAV-mediated muscle-directed gene therapy for hemophilia B.
    Manno, CS
    Herzog, RW
    Arruda, VR
    Couto, LB
    Tai, SJ
    McClelland, A
    Flake, AW
    Chew, AJ
    Fields, PA
    Armstrong, AE
    Leonard, D
    Skarsgard, ED
    Glader, BE
    Ragni, MV
    Larson, PJ
    Kay, MA
    High, KA
    BLOOD, 1999, 94 (10) : 642A - 642A
  • [10] A phase I trial of AAV-mediated muscle directed gene transfer for hemophilia B.
    Manno, CS
    Glader, B
    Ragni, MV
    Thompson, A
    Costa, FF
    Chew, AJ
    Herzog, RW
    Arruda, VR
    Couto, LB
    Clelland, AM
    Johnson, F
    Flake, A
    Skarsgard, E
    Armstrong, E
    Kay, M
    High, KA
    BLOOD, 2000, 96 (11) : 801A - 801A
12345